13z-integrin subunit (CD18) plays an essential role in leukocyte recruitment and adhesion in sites of endothelial injury. We analyzed the surface expression of CD18 on T lymphocytes and monocytes in a series of patients presenting acute coronary syndrome (ACS) who underwent primary percutaneous intervention (PCI) for coronary artery revascularization. We found that basal CD18 expression on peripheral bloodderived CD4+(but not CD8+) T lymphocytes was significantly increased in ACS patients as compared with age-matched healthy volunteers. During primary PCI, a significant increase in CD18 molecule density was detected immediately after balloon deflation (reperfusion) on both CD4+ T cells and monocytes obtained from the right atrium (RT) as compared with basal values. These data suggest that upregulation of CD18 molecules plays an important role in local recruitment of CD4+ T cells and monocytes to the site of endothelial damage after ischemialreperfusion, therefore being responsible, at least in part, for the inflammatory-mediated complications associated with primary PCI.
Primary PCI has emerged as an effective therapeutic procedure in treating patients' with ACS (l). This condition includes either ST and non-ST elevation myocardial infarction (STEMI and NSTEMI, respectively), or unstable angina (UA). PCI has been associated with higher artery patency and flow grades, and lesser frequency of either infarct-related reocclusion or intracranial bleeding than thrombolytic therapy (2) . Many patients with STEMI who are considered ineligible for lytic therapy have been successfully treated with PCI (3). More recently, the incorporation of intracoronary stenting and adjunctive pharmacological therapy has been found to further increase the efficacy of this procedure (4) .
Nevertheless, it has been shown in many experimental models that recanalization of occluded coronary arteries may produce myocardial damage, which is designated as ischemia/reperfusion (I1R) injury. In this regard, numerous studies have demonstrated that the infiltration of leukocytes, including neutrophils, monocytes, and lymphocytes, occurs precociously in the reperfused myocardium (5) . After reperfusion, these inflammatory cells firmly adhere to the endothelium and migrate to the site of injury, possibly amplifying tissue damage. An increase in infarct size and/or occurrence of instent restenosis may be the negative consequences of this process (6) .
Different molecules expressed on leukocytes are involved in adhesion of inflammatory cells to the injured endothelium. A critical role is played by the~2-integrin chain (CD 18) that forms heterodimers with the a subunits CD II a or CD II b to assemble LFA-I or Mac-I molecules , respectively. LFA-I is expressed on lymphocytes, neutrophils, and monocytes, whereas Mac-l is expressed on neutrophils and monocytes. Activation with consequent conformational change of integrins after binding to one of the intercellular adhesion molecules on the surface ofendothelial cells (ICAM-I or ICAM-2) allows firm adhesion, transendothelial migration, and infiltration of inflammatory cells into the injured tissue (7) .
In this study, we analyzed CD 18 expression on peripheral and RA blood-derived CD4+ T lymphocytes and CD8+ T lymphocytes as well as monocytes before and during primary PCI with stent implantation in a series of patients presenting ACS.
MATERIAL AND METHODS

Patient population
Study population included 18ACS patients referred to the Emergency Department of "La Sapienza" University Hospital of Rome, Italy, and II age-matched volunteers without any history of coronary disease. All ACS patients presented within 9-12 h of onset of symptoms characteristic of myocardial ischemia not responsive to nitrates, with or without significant STsegment elevation. and diagnosed either as STEMI. NSTEMI or UA. Patients with cardiogenic shock were excluded. STEMI patients received half-dose thrombolytic treatment plus glycoprotein lIb/IlIa antagonists (combo-therapy) in the Emergency Department before PCI procedure. Patients were treated with primary PCI accordingly to ACC/AHA guidelines for the management of ACS. Angioplasty was done accordingly to local standards with the intention ofreestablishing blood flow in the infarct-related artery as soon as possible, with initial passage of a guidewire, balloon dilatation and coronary stent implantation. After the procedure, the sheaths were removed, and patients were treated in the Coronary Care Unit. Tab. I summarizes the characteristic of all ACS patients included in this study. The additional 11 age-matched volunteers were used as controls for comparison with ACS patients in basal conditions. Approval was obtained from our institutional review board, as well as a written consent from each subject included in this study.
Flow cytometry analysis of CDJ8 expression on mononuclear cells
Blood samples were collected from both brachial vein (BV) and RA in heparinized vials either before, immediately or 15 min after balloon deflation, and kept on ice until further study. Mononuclear cells (MC) were isolated by Lymphoprep (Nycomed Pharma, Oslo, Norway) gradient centrifugation, washed and resuspended at 1 X 10 6 cells/ml in RPMI 1640 medium (Gibco Laboratories, Grand Island, NY) supplemented with 5% human AB serum (Hyclone Laboratories, Logan, UT), 2 j.LM L-glutamine, I j.LM sodium pyruvate, 100VIm Ipennicillin and 100 u.g/rnlstreptomycin (Flow Laboratories, Irvine, Ayrshire). Before flow cytometry analysis, cells were washed and then resuspended in phosphate buffer solution (PBS).
MC were incubated with purified anti-CD 18 monoclonal antibody (mAb) (anti-Leu-Me, BD, San Jose, CA) for 20 min at room temperature, washed and then incubated with fluorescein isothiocyanate(FITC)conjugated goat anti-mouse (GAM) antibody (BD) for 20 min. at 4°C. After a further washing, cells were incubated with mouse serum for 15min. at4°C, washed and incubated with phycoerythrin(PE)-conjugated anti-CD4 or anti-CD8 mAbs (Caltag Laboratories, for 30 min. at 4°C. Acquisition and double-staining analysis of cell samples (1 x 10 4 cells/sample) were performed using a FACScan flow cytometer and CellQuest software (BD). Monocytes and lymphocytes were identified by an electronic gate based upon forward and side scatter diagrams. Negative controls consisted of cells stained with FITC-conjugated isotype-rnatched irrelevant mAb. Each experiment was performed in duplicate.
Statistical analysis
Differences between groups were analyzed by two-tailed Student t test for either unpaired or paired data. A p value < 0.05 was considered statistically significant.
RESULTS
CDJ8 expression on monocytes and T cells
CD 18 molecules were detectable on virtually all MC (> 99%) isolated from either ACS or control subjects. Therefore, differences among samples observed by flow cytometry consisted of changes in the density of this molecule on the cell surface as measured by mean fluorescence intensity.
Firstly, CD J8 expression was analyzed on both monocytes and T lymphocytes from the peripheral blood of ACS patients or healthy subjects. We found that CD 18 expression was significantly higher on CD4+ T cells (mean ± SEM: 58 ± 2.87 vs. 40.6 ± 2.64; p-c .00 I), but not on CD8+ T cells or monocytes, in ACS patients as compared with the control group (Fig. 1) . We then analyzed CD 18 expression on T cells and monocytes obtained from the RA in ACS patients during different phases of PCI. We found that CDl8 expression increased significantly on both monocytes (220.16 ±20.53 vs. 289± 27.5; p<O.OI) and CD4+T (44.72 ± 2.8 vs. 54.22 ± 2.76; P< 0.01) but not on CD8+ T lymphocytes immediately after reperfusion (balloon deflation) as compared with pre-procedural values.. Fifteen minutes after starting myocardial reperfusion, CD 18 expression on all analyzed cell types did not differ significantly from basal values. Parallel analysis ofCD 18 expression in peripheral blood obtained from the brachial vein did not display any significant change on either T cells or monocytes (Fig. 2) . In Fig. 3 on CD4+ T cells from a representative patient either before or immediately after balloon deflation is shown. No significant differences in CDl8 expression either before or during the course of PCI among STEMI, NSTEMI, or UA patient groups were detected, and no significant correlation between CD 18 expression and any individual risk factor was found.
DISCUSSION
The pathology of coronary stenting has been clearly associated with local inflammatory reactions leading to early thrombus deposition and neointimal formation (8) (9) . In addition, several systemic and local markers of inflammation have been reported when defining patients with coronary disease that are at high risk of acute myocardial ischemia (10) . Several studies have pointed out the importance of C018 expression on endothelial injury. Antibodies that inhibit LFA-I adhesion are effective in blocking transmigration (11), and LFA-1 deficient mice show dramatically decreased inflammatory cell extravasation at the site of inflammation (12) . Anti-C018 antibodies have also been shown to reduce infarct size and preserve left ventricular function in an experimental myocardial infarction canine model (13) . In addition, C018-deficient mice show a reduction in myocardial necrosis following ischemia and reperfusion (14) .The finding that anti-inflammatory activity of statins has been attributed at least in part to the blocking of LFAl-mediated adhesion and costimulation of lymphocytes is also of interest (15) . Our data therefore suggest that CO 18 overexpression on C04+ T cells might play an important initial role in inflammation after coronary stenting, and thereby could be involved in the complications that may follow this procedure. Although we did not investigate in this study the possible increase in the expression of CD 11 chains, it can be supposed that enhanced expression of CD 18 might favor 8 2 - integrin heterodimer assembly. Moreover, it can be suggested that the evaluation of CD18expression by flow cytometry could be an additional tool used at the cellular level to detect a myocardial ischemia-associated inflammatory response.
Cytokines, including tumor necrosis factor (TNF-a) and interferon (IFN)-'Y, have been reported to upregulate CD 18 expression on leukocytes (16, 17) . However, many other factors might affect the modulation of CD 18 membrane expression in I1R conditions. When inflammatory cells expressing high levels of C018 are recruited to the site of endothelium injury, they adhere firmly to the endothelium and are, thus, no longer easily obtainable by blood drawing. This may explain why cellular CD 18 upregulation was no longer detectable 15 min after starting reperfusion. In comparison to other studies, it is of interest to note that in our study the analysis of a membraneexpressed molecule has been performed on cells isolated from the RA instead of from the coronary sinus (CS). Although analysis of blood from the RA could be partially biased by a dilution factor as compared with CS, which is anatomically closer to the site of endothelial injury, the RA appears to be a reliable alternative site for the study of locally circulating inflammatory cells after myocardial II R injury. This finding could be of particular value since blood drawing from the RA is easier and safer than from the CS in critically ill patients presenting acute myocardial ischemia.
Another relevant finding from this study is that CD 18 expression was increased on C04+but not C08+ T cells. These two T lymphocyte subpopulations play different roles in immunity and inflammation. In fact, C04+T cells are mainly devoted to producing either pro-inflammatory (lL-2, IFN-'Y, TNF-a) or anti-inflammatory (lL-lO, IL-4) cytokines, whereas C08+ T cells represent the cytotoxic arm of adaptive cellular immunity whose main function is to kill intracellular pathogeninfected cells. Additional study to investigate the balance between the CD4+T cell pro-inflammatory (T helper-I) and anti-inflammatory (T helper-2) subsets in the course of reperfusion is therefore needed.
In conclusion, our data demonstrate that CD 18 molecule expression is increased on peripheral blood-circulating C04+ T lymphocytes in patients presenting ACS as compared to subjects without coronary disease. A local increase of CD 18 expression on both CD4+ T cells and monocytes obtained from the RA was also detected immediately after myocardial reperfusion in ACS patients during the course of PCI. This last finding suggests that the overexpression of CD18 by T cells and monocytes found locally could be an important step in the inflammatory cascade triggered by I1R, withconsequent amplification of endothelial damage and/or triggering of the in-stent restenosis process. It must be emphasized, however, that the finding that CD 18expression changes may reach statistical significance does not necessarily mean that this increase is biologically meaningful. Moreover, many other molecules, including P-selectin glycoprotein ligand (PSGL), playa major role in adhesion, this being a very complex biological phenomenon. Further study of larger patient populations and invitroadhesion assays are therefore needed to clarify the clinical relevance of these data.
